All values are presented as means SD, except where noted
While most SOCs manifested within the first month of medication use, our results indicated that the median time to onset of hepatobiliary disorders was 35.5 days (IQR 4.75154 days)
[PMID: 18551009] PubMed record related to this compound for laboratory literature review
Specifically, the study finds that low GIP levels are associated with optimal tirzepatide response, whereas low GLP-1 levels and intermediate-to-high GIP levels are associated with optimal semaglutide response
Multi-Fiber provides 9g of fiber per serving from 3 complementary sources, delivering both soluble and insoluble fiber to help support regularity, digestive health, and satiety
The case report indicates that no abnormalities were identified in the medical evaluations and symptoms only resolved after stopping the use of semaglutide